Literature DB >> 34048723

SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?

James L Alexander1, Nick Powell2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34048723      PMCID: PMC8149174          DOI: 10.1016/S2468-1253(21)00184-9

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


× No keyword cloud information.
  6 in total

1.  Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study.

Authors:  Matthew J Grainge; Joe West; Timothy R Card
Journal:  Lancet       Date:  2010-02-08       Impact factor: 79.321

2.  Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?

Authors:  W Miehsler; W Reinisch; E Valic; W Osterode; W Tillinger; T Feichtenschlager; J Grisar; K Machold; S Scholz; H Vogelsang; G Novacek
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

Review 3.  SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement.

Authors:  James L Alexander; Gordon W Moran; Daniel R Gaya; Tim Raine; Ailsa Hart; Nicholas A Kennedy; James O Lindsay; Jonathan MacDonald; Jonathan P Segal; Shaji Sebastian; Christian P Selinger; Miles Parkes; Philip J Smith; Anjan Dhar; Sreedhar Subramanian; Ramesh Arasaradnam; Christopher A Lamb; Tariq Ahmad; Charlie W Lees; Liz Dobson; Ruth Wakeman; Tariq H Iqbal; Ian Arnott; Nick Powell
Journal:  Lancet Gastroenterol Hepatol       Date:  2021-01-26

4.  Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD.

Authors:  Nicholas A Kennedy; Simeng Lin; James R Goodhand; Nick Powell; Tariq Ahmad; Neil Chanchlani; Benjamin Hamilton; Claire Bewshea; Rachel Nice; Desmond Chee; Jr Fraser Cummings; Aileen Fraser; Peter M Irving; Nikolaos Kamperidis; Klaartje B Kok; Christopher Andrew Lamb; Jonathan Macdonald; Shameer Mehta; Richard Cg Pollok; Tim Raine; Philip J Smith; Ajay Mark Verma; Simon Jochum; Timothy J McDonald; Shaji Sebastian; Charlie W Lees
Journal:  Gut       Date:  2021-04-26       Impact factor: 31.793

5.  Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study.

Authors:  Anton Pottegård; Lars Christian Lund; Øystein Karlstad; Jesper Dahl; Morten Andersen; Jesper Hallas; Øjvind Lidegaard; German Tapia; Hanne Løvdal Gulseth; Paz Lopez-Doriga Ruiz; Sara Viksmoen Watle; Anders Pretzmann Mikkelsen; Lars Pedersen; Henrik Toft Sørensen; Reimar Wernich Thomsen; Anders Hviid
Journal:  BMJ       Date:  2021-05-05

6.  Cerebral venous thrombosis and portal vein thrombosis: A retrospective cohort study of 537,913 COVID-19 cases.

Authors:  Maxime Taquet; Masud Husain; John R Geddes; Sierra Luciano; Paul J Harrison
Journal:  EClinicalMedicine       Date:  2021-07-31
  6 in total
  2 in total

Review 1.  Review of COVID-19 viral vector-based vaccines and COVID-19 variants.

Authors:  Rachana Vanaparthy; Gisha Mohan; Deepa Vasireddy; Paavani Atluri
Journal:  Infez Med       Date:  2021-09-10

2.  Effectiveness and Safety of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease.

Authors:  Emily Spiera; Ryan C Ungaro; Asher Kornbluth
Journal:  Gastroenterol Hepatol (N Y)       Date:  2022-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.